OLFML2B and nonpapillary renal cell carcinoma: Here, we proved that OLFML2B contributed to the proliferation and metastasis of ccRCC, affirming its prognostic efficacy for ccRCC patients through colony formation assays, EdU assays, and xenograft experiments, as well as provided new ideas for clinical work.